AVITA Medical Statistics
Total Valuation
AVITA Medical has a market cap or net worth of $266.20 million. The enterprise value is $276.30 million.
Important Dates
The next confirmed earnings date is Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AVITA Medical has 26.43 million shares outstanding. The number of shares has increased by 2.18% in one year.
| Current Share Class | 26.43M |
| Shares Outstanding | 26.43M |
| Shares Change (YoY) | +2.18% |
| Shares Change (QoQ) | +0.62% |
| Owned by Insiders (%) | 1.76% |
| Owned by Institutions (%) | 24.71% |
| Float | 25.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.06 |
| Forward PS | 2.54 |
| PB Ratio | 58.99 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.83, with a Debt / Equity ratio of 10.22.
| Current Ratio | 2.83 |
| Quick Ratio | 2.37 |
| Debt / Equity | 10.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.27 |
Financial Efficiency
Return on equity (ROE) is -230.96% and return on invested capital (ROIC) is -49.84%.
| Return on Equity (ROE) | -230.96% |
| Return on Assets (ROA) | -36.97% |
| Return on Invested Capital (ROIC) | -49.84% |
| Return on Capital Employed (ROCE) | -95.03% |
| Revenue Per Employee | $247,119 |
| Profits Per Employee | -$237,865 |
| Employee Count | 260 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 1.41 |
Taxes
In the past 12 months, AVITA Medical has paid $54,000 in taxes.
| Income Tax | 54,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.92% in the last 52 weeks. The beta is 1.60, so AVITA Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.60 |
| 52-Week Price Change | +16.92% |
| 50-Day Moving Average | 8.97 |
| 200-Day Moving Average | 10.13 |
| Relative Strength Index (RSI) | 64.96 |
| Average Volume (20 Days) | 198,270 |
Short Selling Information
| Short Interest | 2.45M |
| Short Previous Month | 2.35M |
| Short % of Shares Out | 9.37% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 12.13 |
Income Statement
In the last 12 months, AVITA Medical had revenue of $64.25 million and -$61.85 million in losses. Loss per share was -$2.39.
| Revenue | 64.25M |
| Gross Profit | 55.16M |
| Operating Income | -56.59M |
| Pretax Income | -49.74M |
| Net Income | -61.85M |
| EBITDA | -55.47M |
| EBIT | -56.59M |
| Loss Per Share | -$2.39 |
Full Income StatementBalance Sheet
The company has $35.89 million in cash and $45.99 million in debt, giving a net cash position of -$10.10 million or -$0.38 per share.
| Cash & Cash Equivalents | 35.89M |
| Total Debt | 45.99M |
| Net Cash | -10.10M |
| Net Cash Per Share | -$0.38 |
| Equity (Book Value) | 4.50M |
| Book Value Per Share | 0.17 |
| Working Capital | 36.84M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$48.94 million and capital expenditures -$9.17 million, giving a free cash flow of -$58.11 million.
| Operating Cash Flow | -48.94M |
| Capital Expenditures | -9.17M |
| Free Cash Flow | -58.11M |
| FCF Per Share | -$2.20 |
Full Cash Flow StatementMargins
Gross margin is 85.85%, with operating and profit margins of -88.08% and -96.26%.
| Gross Margin | 85.85% |
| Operating Margin | -88.08% |
| Pretax Margin | -96.17% |
| Profit Margin | -96.26% |
| EBITDA Margin | -86.33% |
| EBIT Margin | -88.08% |
| FCF Margin | n/a |
Dividends & Yields
AVITA Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.18% |
| Shareholder Yield | -2.18% |
| Earnings Yield | -23.23% |
| FCF Yield | -21.83% |
Analyst Forecast
The average price target for AVITA Medical is $17.25, which is 72.16% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.25 |
| Price Target Difference | 72.16% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 41.99% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on June 30, 2020. It was a reverse split with a ratio of 0.2:1.
| Last Split Date | Jun 30, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.2:1 |
Scores
AVITA Medical has an Altman Z-Score of -4.89 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.89 |
| Piotroski F-Score | 3 |